Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma
Abstract Lung adenocarcinoma (LUAD) is one of the leading causes of cancer-related deaths worldwide, with a 5-year survival rate of approximately 19%. With the advent of screening and diagnostic techniques such as low-dose spiral CT and liquid biopsy, the detection rate of early stage LUAD is increa...
Saved in:
| Main Authors: | Qi Zhang, Xiaoli Zhang, Zhuoheng Lv, Huandong Huo, Ligong Yuan, Duo Wan, Peipei Xie, Shujun Cheng, Kaitai Zhang, Wen Zhang, Yousheng Mao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Journal of Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13045-024-01637-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection
by: David Sinclair Thomas Junior, et al.
Published: (2025-05-01) -
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker studyResearch in context
by: Lissa Wullaert, et al.
Published: (2025-09-01) -
Circulating Tumour Cells and FOXP3 in Regulatory T-Cells as New Modalities in Cancer Diagnosis and Metastasis Location Prediction
by: Ikhwan Rinaldi
Published: (2024-01-01) -
Pulmonary tumour embolism from gastric adenocarcinoma causing respiratory and cardiac failure may not be identified on standard ante-mortem imaging
by: Konstantīns Ščerbakovs, et al.
Published: (2025-03-01) -
Advancing breast cancer circulating tumour cell research at the Institute of Oncology Ljubljana
by: Tanja Jesenko, et al.
Published: (2024-12-01)